HRPK20030006B1 - Pharmaceutical disinfective preparations on the basis of usnic acid sodium salt and medical plants and process for their obtaining - Google Patents

Pharmaceutical disinfective preparations on the basis of usnic acid sodium salt and medical plants and process for their obtaining

Info

Publication number
HRPK20030006B1
HRPK20030006B1 HR20030006A HRP20030006A HRPK20030006B1 HR PK20030006 B1 HRPK20030006 B1 HR PK20030006B1 HR 20030006 A HR20030006 A HR 20030006A HR P20030006 A HRP20030006 A HR P20030006A HR PK20030006 B1 HRPK20030006 B1 HR PK20030006B1
Authority
HR
Croatia
Prior art keywords
disinfective
preparations
pharmaceutical
obtaining
basis
Prior art date
Application number
HR20030006A
Other languages
English (en)
Inventor
Stankovic Slobodan
Đor­Evic Ivana
Kocic Zoran
Original Assignee
Farmaceutsko Hemijska Ind Ad Z
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutsko Hemijska Ind Ad Z filed Critical Farmaceutsko Hemijska Ind Ad Z
Publication of HRP20030006A2 publication Critical patent/HRP20030006A2/hr
Publication of HRPK20030006B1 publication Critical patent/HRPK20030006B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/235—Foeniculum (fennel)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20030006A 2000-06-15 2003-01-03 Pharmaceutical disinfective preparations on the basis of usnic acid sodium salt and medical plants and process for their obtaining HRPK20030006B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YUP037300 2000-06-15
PCT/YU2000/000022 WO2001095900A1 (en) 2000-06-15 2000-11-03 Pharmaceutical disinfectants comprising usnic and essential oils

Publications (2)

Publication Number Publication Date
HRP20030006A2 HRP20030006A2 (en) 2003-04-30
HRPK20030006B1 true HRPK20030006B1 (en) 2004-08-31

Family

ID=37012150

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030006A HRPK20030006B1 (en) 2000-06-15 2003-01-03 Pharmaceutical disinfective preparations on the basis of usnic acid sodium salt and medical plants and process for their obtaining

Country Status (8)

Country Link
EP (1) EP1294373B1 (xx)
AU (1) AU2001212552A1 (xx)
DE (1) DE60022689T2 (xx)
EA (1) EA006582B1 (xx)
HR (1) HRPK20030006B1 (xx)
RS (1) RS49778B (xx)
SI (1) SI1294373T1 (xx)
WO (1) WO2001095900A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1190190C (zh) * 2001-11-23 2005-02-23 王卫 一种抗病毒、抗菌的斑蝥酸酐药物组合物及其制备方法
DK1556021T3 (da) * 2002-10-24 2008-04-28 Immupharm As Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
WO2004043436A1 (fr) * 2002-11-13 2004-05-27 Fanzi Cong Aerosol a usage medical comprenant une huile essentielle provenant d'une plante et sa preparation
GB0303677D0 (en) * 2003-02-18 2003-03-19 Quest Int Flavoured products
US8147877B2 (en) 2006-06-01 2012-04-03 Ohso Clean, Inc. Essential oils based disinfecting compositions having tuberculocidal and fungicidal efficacies
US7465697B1 (en) 2006-11-02 2008-12-16 Ohsoclean, Inc. Essential oils based cleaning and disinfecting compositions
IT201900021852A1 (it) * 2019-11-21 2021-05-21 Vestatis Gmbh Composizione di estratti naturali avente attività antibatterica o batteriostatica anche per batteri Gram-negativi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2354517A1 (de) * 1973-10-31 1975-05-28 Handelsgesellschaft Schlosser Kosmetisches praeparat
IT1204901B (it) * 1986-06-25 1989-03-10 Iscofar Sas Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria
RO96751B1 (ro) * 1986-12-29 1989-04-30 Institutul De Cercetari Chimico-Farmaceutice Apa de gura cu extracte de plante
FR2662939B1 (fr) * 1990-06-08 1992-09-18 Beaussier Yann Gel anti-inflammatoire et son procede de fabrication.
DE59912715D1 (de) * 1998-07-13 2005-12-01 Joerg Peter Schuer Antimikrobielle zusammensetzung

Also Published As

Publication number Publication date
SI1294373T1 (sl) 2006-02-28
EP1294373B1 (en) 2005-09-14
DE60022689T2 (de) 2006-06-22
YU37300A (sh) 2002-12-10
EA200300021A1 (ru) 2003-10-30
DE60022689D1 (de) 2005-10-20
EP1294373A1 (en) 2003-03-26
EA006582B1 (ru) 2006-02-24
WO2001095900A1 (en) 2001-12-20
RS49778B (sr) 2008-06-05
HRP20030006A2 (en) 2003-04-30
AU2001212552A1 (en) 2001-12-24

Similar Documents

Publication Publication Date Title
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
NO20032438L (no) Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene
PT1183029E (pt) Preparado farmaceutico contendo contendo o principio activo diamorfina e sua utilizacao num processo para o tratamento da dependencia de opiaceos
HRP20030871A2 (en) Anthranilic acid amides, method for the production therefo, their use as antiarrhytmia agents, and pharmaceutical preparations thereof
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
DE69000997T2 (de) Rasch freisetzendes orales teilchenfoermiges pharmazeutisches praeparat, dessen unangenehmer geschmack maskiert ist.
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
IL139512A0 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloaxacin or its pharmaceutically suitable salts or hydrates
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
PL366212A1 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
HRPK20030006B1 (en) Pharmaceutical disinfective preparations on the basis of usnic acid sodium salt and medical plants and process for their obtaining
IL139817A0 (en) Non-hydrated gabapentin polymorph, a process for the preparation thereof and the use thereof for the preparation of pharmaceutical grade gabapentin
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
EG24584A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of uicerative colitis and crohn's disease
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
FR2793795B1 (fr) Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
HK1045260A1 (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use.
NO20023249D0 (no) Nye substituerte pyrazolo(4,3-e)ediazepiner, farmasöytiske preparater inneholdende disse, anvendelse som medisinske produkterog fremgangsmåter for fremstilling derav
EE200300065A (et) Meetod peptiidsoolade valmistamiseks, nende peptiidsoolade kasutamine ning neid peptiidsooli sisaldavad farmatseutilised preparaadid
NO20020777D0 (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
AIPK Request for the grant of a patent on the basis of a substantive examination of a patent application after grant of consensual patent
ODRP Renewal fee for the maintenance of a patent

Payment date: 20111007

Year of fee payment: 12

ODBI Application refused